EHA Library - The official digital education library of European Hematology Association (EHA)

PRELIMINARY RESULTS OF ACUTE LEUKEMIA EPIDEMIOLOGICAL ESTIMATIONS BASED ON CLINICAL REGISTIRY DATA IN RUSSIA.
Author(s): ,
Zalina Akhmerzaeva
Affiliations:
Acute leukemia department,National Research Center For Hematology,Moscow,Russian Federation
,
Sergey Kulikov
Affiliations:
Biostatistic department,National Research Center For Hematology,Moscow,Russian Federation
,
Mikhail Rusinov
Affiliations:
Biostatistic department,National Research Center For Hematology,Moscow,Russian Federation
,
Lyubov Gavrilova
Affiliations:
Hematological Department,Saransk Clinical Hospital,Saransk,Russian Federation
,
Ekaterina Zotina
Affiliations:
Hematological Department,Kirov Clinical Hospital,Kirov,Russian Federation
,
Alexander Pristupa
Affiliations:
Hematological Department,Ryazan's Clinical Hospital,Ryazan,Russian Federation
,
Natalia Vopilina
Affiliations:
Hematological department,Tambov regional clinical hospital,Tambov,Russian Federation
,
Elena Borisenkova
Affiliations:
Hematological department,Kaluga regional clinical hospital,Kaluga,Russian Federation
Elena Parovichnikova
Affiliations:
BMT department,National Research Center For Hematology,Moscow,Russian Federation
(Abstract release date: 05/21/15) EHA Library. Akhmerzaeva Z. 06/12/15; 102796; PB1643
Zalina Akhmerzaeva
Zalina Akhmerzaeva
Contributions
Abstract
Abstract: PB1643

Type: Publication Only

Background

The incidence of acute leukemia (AL) in US and European countries is about 5 per 100000 according data from cancer registries. Russian Federal ?ancer Register reported AL incidence rate across the country as about 3 per 100000.

Russian Hematology Society in 2013 initiated the AL population based registry study in which participated 8 regions of Russia Federation. The primary goal was to pre-registry patients for clinical studies, and secondary - to evaluate the epidemiology of AL. 5 regions  were included into analysis of epidemiology statistics. The criteria were the fullness and reliability of AL cases registration. Also, only regions with one big hematological center accumulating all AL cases were chosen. All new cases were recorded on-line into special Web based data capture system. 



Aims

To evaluate the age-gender specific incidence, profile and other epidemiologic characteristics AL in Russian regions. 



Methods
The registry was started at 1st April of 2013 and is ongoing. 

Results

169 new ALL cases from Kirov, Ryazan, Kaluga, Tambov regions and Mordovia republic (4,7 M of population) were included into analysis. The distribution by AL subtypes was following:  AML - 109 (74,6%), ALL -  31 (21,2%), APL - 5 (3,4%), other - 1 (0,7%). Median age was for AML - 59 (17-85), ALL -  38 (18-80), APL  54 (38-60) years. Gender female/male proportions in AML were – 18/13, in ALL -  54/55, in APL -  4/1. 105 (62,5%) patients are alive; 58(34,5%) - died, 5 (3%) were withdrawn.

The incidence rate estimates by region are listed in table1. 

Two regions (Kirov region and Mordovia) with longest duration of registration were taken for age specific incidence calculations. Incidence of AL by age is following:  in 15-19 age group – 0.90; in 20-39 age group – 1.13; in 40-59 age group – 2.45; in 60-79 age group – 3.54; in 80-99 age group – 2.18. Total crude incidence in this two regions is 2.09, standardized by WHO population – 1.87.

 



Summary
The first estimations of AL epidemiology in selected Russian regions was made based on direct registration data from hematological centers.  The incidence rate estimations are less than expected. Some explanations may be:  incomplete registration of cases, under -diagnostics of AL, non-admission  of AL patients to hematological center.

Keyword(s): Acute leukemia



Session topic: Publication Only
Abstract: PB1643

Type: Publication Only

Background

The incidence of acute leukemia (AL) in US and European countries is about 5 per 100000 according data from cancer registries. Russian Federal ?ancer Register reported AL incidence rate across the country as about 3 per 100000.

Russian Hematology Society in 2013 initiated the AL population based registry study in which participated 8 regions of Russia Federation. The primary goal was to pre-registry patients for clinical studies, and secondary - to evaluate the epidemiology of AL. 5 regions  were included into analysis of epidemiology statistics. The criteria were the fullness and reliability of AL cases registration. Also, only regions with one big hematological center accumulating all AL cases were chosen. All new cases were recorded on-line into special Web based data capture system. 



Aims

To evaluate the age-gender specific incidence, profile and other epidemiologic characteristics AL in Russian regions. 



Methods
The registry was started at 1st April of 2013 and is ongoing. 

Results

169 new ALL cases from Kirov, Ryazan, Kaluga, Tambov regions and Mordovia republic (4,7 M of population) were included into analysis. The distribution by AL subtypes was following:  AML - 109 (74,6%), ALL -  31 (21,2%), APL - 5 (3,4%), other - 1 (0,7%). Median age was for AML - 59 (17-85), ALL -  38 (18-80), APL  54 (38-60) years. Gender female/male proportions in AML were – 18/13, in ALL -  54/55, in APL -  4/1. 105 (62,5%) patients are alive; 58(34,5%) - died, 5 (3%) were withdrawn.

The incidence rate estimates by region are listed in table1. 

Two regions (Kirov region and Mordovia) with longest duration of registration were taken for age specific incidence calculations. Incidence of AL by age is following:  in 15-19 age group – 0.90; in 20-39 age group – 1.13; in 40-59 age group – 2.45; in 60-79 age group – 3.54; in 80-99 age group – 2.18. Total crude incidence in this two regions is 2.09, standardized by WHO population – 1.87.

 



Summary
The first estimations of AL epidemiology in selected Russian regions was made based on direct registration data from hematological centers.  The incidence rate estimations are less than expected. Some explanations may be:  incomplete registration of cases, under -diagnostics of AL, non-admission  of AL patients to hematological center.

Keyword(s): Acute leukemia



Session topic: Publication Only

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies